Cerus Corp
CERS Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$2.37
KIRA · Stoqly’s AI analyst, in plain words
- Cerus Corp had $234M of revenue in fiscal 2025, up 16.1% on the year before. Over five years, revenue changed +15.4% a year on average.
- Its operating margin was −3.7%, up 3.4 pts: of every 100 in sales, about −4 is left after running the business.
- Cerus Corp lost $15.6M in fiscal 2025.
- Free cash flow was $1.1M in fiscal 2025, 0.5% of revenue.
Market cap
$475M
P/E
—
Revenue
$234M
Net income
−$15.6M
Free cash flow
$1.1M
Operating margin
−3.7%
Cerus Corp in 30 seconds · fiscal 2025
Are sales growing?
+16.1%
Yes. Sales grew 16.1% last year.
Does it make a profit?
−6.7%
No. It lost money last year.
Does profit turn into cash?
0.5%
Partly. 0.5% of sales ends up as free cash.
How healthy are the accounts?
4 / 7
Mixed. It passes 4 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Cerus Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 2, 2026
- Legal name
- CERUS CORP
- CIK
- 0001020214
Cerus Corp · CERS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $160M | $188M | $187M | $201M | $234M |
| Revenue growth | 39.6% | 18.1% | −0.8% | 7.8% | 16.1% |
| Operating margin | −30.7% | −18.1% | −16.1% | −7.1% | −3.7% |
| Net income | −$54.4M | −$42.8M | −$37.5M | −$20.9M | −$15.6M |
| Net margin | −34.1% | −22.7% | −20.1% | −10.4% | −6.7% |
| Diluted EPS | −$0.32 | −$0.24 | −$0.21 | −$0.11 | −$0.08 |
| Cash | |||||
| Cash from operations | −$33.9M | −$25.6M | −$43.2M | $11.4M | $4.8M |
| Capital expenditure | $0.9M | $2.0M | $4.6M | $2.8M | $3.7M |
| Free cash flow | −$34.8M | −$27.6M | −$47.8M | $8.5M | $1.1M |
| FCF margin | −21.8% | −14.7% | −25.6% | 4.2% | 0.5% |
| Share count change | 4.5% | 3.1% | 2.1% | 2.4% | 3.3% |
| Debt and strength | |||||
| Cash and short-term investments | $129M | $102M | $65.9M | $80.5M | $82.9M |
| Shareholders' equity | $84.6M | $67.6M | $52.7M | $56.1M | $64.2M |
| Current ratio | 2.4x | 1.5x | 2.1x | 2.4x | 1.7x |
| Interest coverage | −9.9x | −5.8x | −3.6x | −1.6x | −1.0x |
| Returns and quality | |||||
| Return on equity | −57.7% | −56.2% | −62.3% | −38.5% | −26.0% |
| Return on tangible equity | −65.3% | −64.5% | −73.0% | −38.2% | −24.8% |
| Piotroski F-score | 3 | 3 | 3 | 5 | 4 |
| Altman Z'' | −11.0 | −14.0 | −15.3 | −14.5 | −13.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$3.1M
6 insiders
Of sales under plans
98%
$3.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cerus Corp · CERS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.37 a share, the company is worth $475M.
Source: SEC EDGAR XBRL filings (CIK 0001020214). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.